Abstract
Although anti-mitochondrial antibody (AMA) is the characteristic serological feature of primary biliary cirrhosis (PBC), its pathogenetic role remains unclear. We tested sera from 72 Japanese patients with histologically confirmed PBC for AMA by indirect immunofluorescence, anti-pyruvate dehydrogenase complex (PDC) by enzyme inhibition assay, immunoglobulin (Ig) G class anti-PDC by ELISA, and IgG, IgM, and IgA class anti-2-oxo-acid dehydrogenase complex (2-OADC) by immunoblotting. Of the 72 sera, 60 (83%), 50 (69%), 42 (58%), and 71 (99%) were positive for AMA by immunofluorescence, enzyme inhibition assay, ELISA, and immunoblotting, respectively. There was no significant correlation between histological stages and AMA by immunofluorescence, PDC inhibitory antibodies by enzyme inhibition assay, IgG class anti-PDC antibodies by ELISA, or IgG and IgM class anti-2-OADC by immunoblotting. IgA class anti-2-OADC by immunoblotting was more frequent in stages 2–4 than in stage 1 (P = 0.0083). Of the IgA class anti-2-OADC, anti-PDC-E2 (74 kDa) and anti-E3BP (52 kDa) were more frequent in stages 2–4 than in stage 1 (P = 0.0253 and 0.0042, respectively). Further examination of histopathological findings in 53 of 72 liver biopsy specimens showed that IgA class anti-PDC-E2 and IgA class anti-E3BP were associated with bile duct loss, and IgA class anti-PDC-E2 was also associated with interface hepatitis and atypical ductular proliferation. IgA is known to be secreted into the bile through biliary epithelial cells, implying that IgA class anti-PDC-E2 and E3BP may have a specific pathogenetic role during their transport into the bile by binding to their target antigen(s) in biliary epithelial cells, and this may be followed by dysfunction and finally destruction of biliary epithelial cells. Our present results suggest that these autoantibodies against 2-OADC detected by immunoblotting may be associated with the pathogenesis and pathologic progression of PBC.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Kaplan MM: Primary biliary cirrhosis. N Engl J Med 335:1570-1580, 1996
Mackay IR, Gershwin ME: Pathogenesis of primary biliary cirrhosis. In Autoimmune Liver Diseases, 2nd ed. EL Krawitt, RH Wiesner, M Nishioka (eds). Amsterdam, Elsevier, 1998, pp 49-69
Heseltine L, Turner IB, Fussey SPM, Kelly PJ, James OFW, Yeaman SJ, Bassendine MF: Primary biliary cirrhosis. Quantitation of autoantibodies to purified mitochondrial enzymes and correlation with disease progression. Gastroenterology 99:1786-1792, 1990
Van Norstrand MD, Malinchoc M, Lindor KD, Therneau TM, Gershwin ME, Leung PSC, Dickson ER, Homburger HA: Quantitative measurement of autoantibodies to recombinant mitochondrial antigens in patients with primary biliary cirrhosis: relationship of levels of autoantibodies to disease progression. Hepatology 25:6-11, 1997
Jones DEJ: Autoantigens in primary biliary cirrhosis. J Clin Pathol 53:813-821, 2000
Invernizzi P, Podda M, Battezzati PM, Crosignani A, Zuin M, Hitchman E, Maggioni M, Meroni PL, Penner E, Wesierska-Gadek J: Autoantibodies against nuclear pore complexes are associated with more active and severe liver disease in primary biliary cirrhosis. J Hepatol 34:366-372, 2001
Joshi S, Cauch-Dudek K, Heathcote EJ, Lindor K, Jorgensen R, Klein R: Antimitochondrial antibody profiles: are they valid prognostic indicators in primary biliary cirrhosis? Am J Gastroenterol 97:999-1002, 2002
Kisand KE, Kisand KV, Karvonen A-L, Vuoristo M, Mattila J, Makinen J, Uibo R: antibodies to pyruvate dehydrogenase in primary biliary cirrhosis: correlation with histology. APMIS 106:884-892, 1998
Scheuer PJ, Lefkowitch JH: Liver Biopsy Interpretation, 6th ed. London, WB Saunders, 2000
Hazama H, Omagari K, Masuda J, Ohba K, Kinoshita H, Matsuo I, Isomoto H, Mizuta Y: Automated enzymatic mitochondrial antibody assay for the diagnosis of primary biliary cirrhosis: applications of a routine diagnostic tool for the detection of antimitochondrial antibodies. J Gastroenterol Hepatol 17:316-323, 2002
Takemura M, Ohya K, Kojima K: Fundamental evaluation of MESACUP-2 Test Mitochondrial M2. Jpn J Med Pharm Sci 46:809-816, 2001 (in Japanese)
Stanley CJ, Perham RN: Purification of 2-oxo acid dehydrogenase multienzyme complexes from ox heart by a new method. Biochem J 191:147-154, 1980
Kinoshita H, Omagari K, Matsuo I, Yamaguchi K, Ikuno N, Kohno S: Frequency of IgG, IgM, and IgA class autoantibodies against 2-oxo-acid dehydrogenase complex in 102 Japanese patients with primary biliary cirrhosis. Hepatol Res 15:163-171, 1999
Itoh S, Ichida T, Yoshida T, Hayakawa A, Uchida M, Tashiro-Itoh T, Matsuda Y, Ishihara K, Asakura H: Autoantibodies against a 210 kDa glycoprotein of the nuclear pore complex as a prognostic marker in patients with primary biliary cirrhosis. J Gastroenterol Hepatol 13:257-265, 1998
Corpechot C, Benlian P, Barbu V, Chazouilleres O, Poupon RE, Poupon R: Apolipoprotein E polymorphism, a marker of disease severity in primary biliary cirrhosis? J Hepatol 35:324-328, 2001
Donaldson P, Agarwal K, Craggs A, Craig W, James O, Jones D: HLA and interleukin 1 gene polymorphisms in primary biliary cirrhosis: associations with disease progression and disease susceptibility. Gut 48:397-402, 2001
Metcalf JV, Mitchison HC, Palmer JM, Jones DE, Bassendine MF, James OFW: Natural history of early primary biliary cirrhosis. Lancet 348:1399-1402, 1996
Nagura H, Sumi Y, Fukuda Y, Hasegawa H, Watanabe K, Brown WR: Studies on the relationships of IgA to human liver. IgA deposition in non-alcoholic liver diseases. Acta Pathol Jpn 39:363-372, 1989
Sugiura H, Nakanuma Y: Secretory component and immunoglobulins in the intrahepatic biliary tree and peribiliary gland in normal livers and hepatolithiasis. Gastroenterol Jpn 24:308-314, 1989
Nishio A, Van de Water J, Leung PSC, Joplin R, Neuberger JM, Lake J, Bjorkland A, Totterman TH, Peters M, Worman HJ, Ansari AA, Coppel RL, Gershwin ME: Comparative studies of antimitochondrial autoantibodies in sera and bile in primary biliary cirrhosis. Hepatology 25:1085-1089, 1997
Floreani A, Baragiotta A, Pizzuti D, Martines D, Cecchetto A, Chiarelli S: Mucosal IgA defect in primary biliary cirrhosis. Am J Gastroenterol 97:508-510, 2002
Fukushima N, Nalbandian G, Van de Water J, White K, Ansari AA, Leung P, Kenny T, Kamita SG, Hammock BD, Coppel RL, Stevenson F, Ishibashi H, Gershwin ME: Characterization of recombinant monoclonal IgA anti-PDC-E2 autoantibodies derived from patients with primary biliary cirrhosis. Hepatology 36:1383-1392, 2002
Joplin RE, Wallace LL, Lindsay JG, Palmer JM, Yeaman SJ, Neuberger JM: The human biliary epithelial cell plasma membrane antigen in primary biliary cirrhosis: pyruvate dehydrogenase X? Gastroenterology 113:1727-1733, 1997
Nakanuma Y, Tsuneyama K, Harada K: Pathology and pathogenesis of intrahepatic bile duct loss. J Hepatobiliary Pancreat Surg 8:303-315, 2001
Nakajima M, Shimizu H, Miyazaki A, Watanabe S, Kitami N, Sato N: Detection of IgA, IgM, and IgG subclasses of anti-M2 antibody by immunoblotting in autoimmune cholangitis: Is autoimmune cholangitis an early stage of primary biliary cirrhosis? J Gastroenterol 34:607-612, 1999
Masuda J, Omagari K, Miyakawa H, Hazama H, Ohba K, Kinoshita H, Matsuo I, Isomoto H, Murata I, Kohno S: Clinical significance of positive immunoblotting but negative immunofluorescence for antimitochondrial antibodies in patients with liver diseases other than primary biliary cirrhosis. Autoimmunity 35:135-141, 2002
Inoue K, Hirohara J, Nakano T, Seki T, Sasaki H, Higuchi K, Ohta Y, Onji M, Muto Y, Moriwaki H: Prediction of prognosis of primary biliary cirrhosis in Japan. Liver 15:70-77, 1995
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Masuda, JI., Omagari, K., Ohba, K. et al. Correlation Between Histopathological Findings of the Liver and IgA Class Antibodies to 2-Oxo-Acid Dehydrogenase Complex in Primary Biliary Cirrhosis. Dig Dis Sci 48, 932–938 (2003). https://doi.org/10.1023/A:1023055714208
Issue Date:
DOI: https://doi.org/10.1023/A:1023055714208